Remove Biopharma Remove Healthcare Provider Remove Management Remove Pharmaceutical products
article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. Regulatory manager at a fortune 500 company Implications for stakeholders: As regulations evolve, so must the industry.